Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-014482
Filing Date
2025-05-23
Accepted
2025-05-23 16:30:14
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 form4-05232025_040506.html 4  
1 form4-05232025_040506.xml 4 4370
  Complete submission text file 0001415889-25-014482.txt   5801
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Issuer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIRIDIAN THERAPEUTICS, INC. 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address
Humer Kristian (Reporting) CIK: 0001872280 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39980 | Film No.: 25982857